ILPIP Activators
ILPIP activators enhance the signaling capabilities of ILPIP through various cellular mechanisms. Compounds like Forskolin and PMA, through their action on adenylyl cyclase and PKC respectively, facilitate an increase in intracellular messengers such as cAMP and diacylglycerol. This elevation in secondary messengers results in the activation of kinases like PKA, which are known to phosphorylate target proteins including ILPIP, thus potentiating its role in cellular processes like lipid signaling and ion transport. Similarly, Ionomycin and A23187, both calcium ionophores, raise intracellular calcium levels, a critical component of many signaling pathways. This increase in calcium may activate or enhance pathways where ILPIP is a critical component, thereby augmenting its cellular functions.
On the other hand, LY294002 and U0126 act as inhibitors of PI3K and MEK1/2, respectively, leading to an intricate reprogramming of cellular signaling networks that may compensate by enhancing ILPIP's activity. SB203580's inhibition of p38 MAPK also shifts cellular signaling, potentially channeling towards ILPIP-involved pathways, enhancing its role in the cellular response to stress and inflammation. The kinase inhibitory actions of Epigallocatechin Gallate and Staurosporine may similarly reroute signaling to favor ILPIP's activation. In contrast, Sphingosine-1-phosphate operates through its receptors to possibly engage ILPIP in signaling cascades related to cell migration orangiogenesis. Lastly, Genistein's inhibition of tyrosine kinases could relieve inhibitory control over ILPIP-associated pathways, promoting its function in processes such as growth factor signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels, which in turn activates PKA. PKA can then phosphorylate and enhance the activity of ILPIP in cellular processes such as lipid signaling or ion transport. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate ILPIP, thereby increasing its activity in signal transduction pathways associated with cellular growth and differentiation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels and potentially activating calcium-sensitive pathways that ILPIP may be a part of, thereby enhancing its function in calcium signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to the activation of compensatory pathways which may include the enhancement of ILPIP's signaling function in the PI3K/Akt pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can redirect cellular signaling towards alternative pathways that might enhance the activity of ILPIP in stress response or inflammation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, activating calcium-dependent signaling pathways and thus potentially enhancing ILPIP's functional activity related to ion transport or signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium which may activate pathways involving ILPIP. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a kinase inhibitor, can lead to the activation of alternative pathways that might enhance ILPIP activity, particularly in signaling pathways related to cellular metabolism. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate interacts with its receptors to modulate signaling pathways that may include the activation of ILPIP in processes such as cell migration or angiogenesis. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, may shift signaling dynamics to enhance the activity of ILPIP, particularly in pathways involving growth factor signaling. | ||||||